Hydrafacial Results Presentation Deck
Q4 2022 cost detail
($mm)
Gross Profit
Selling &
Marketing
G&A
R&D
24
Q4 2022 Q4 2021 Δ Q4 2021 Q4 2022
$65.2
39.0
28.5
1.4
$56.8
37.1
25.0
1.9
+$8.4
+2.0
+3.4
(0.4)
66.4%
39.8%
29.0%
1.5%
% net sales
Q4 2021
72.9%
47.6%
32.2%
2.4%
Δ Q4 2021 Δ Commentary
(6.5%)
(7.8%)
(3.1%)
(0.9%)
Trade-up volumes, Syndeo initial program
logistics and servicing costs, raw material
write-offs, warranty reserves, global supply
chain challenges, inflationary pressures and
foreign exchange headwinds
Increases in sales commissions associated
with higher revenues partially offset by
leverage of fixed marketing investment
Increase in stock-based compensation,
personnel-related expenses and professional
fees relating to SOX implementation, partially
offset by fixed cost leverage
Lapping of Syndeo development costs,
partially offset by investments in data
infrastructure
BEAUTYHEALTH™View entire presentation